01/19 | ASTRAZENECA : India to start COVID vaccine exports on Wednesday | RE |
01/19 | ASTRAZENECA : India to start COVID vaccine exports on Wednesday | RE |
01/19 | AMGEN : Morgan Stanley Adjusts Amgen PT to $285 From $276, Maintains Overweight .. | MT |
01/19 | BIOGEN : Morgan Stanley Adjusts Biogen PT to $352 From $357, Maintains Overweigh.. | MT |
01/19 | ELI LILLY AND : Mizuho Upgrades Eli Lilly and Co. to Buy from Neutral, Adjusts P.. | MT |
01/19 | SANOFI : Gets a Buy rating from UBS | MD |
01/19 | Sputnik-AstraZeneca vaccine trials to start in February, says R-Pharm | RE |
01/19 | Philippines to buy 20 million Moderna vaccine doses as COVID-19 cases rise | RE |
01/19 | NOVARTIS AG : JP Morgan reaffirms its Sell rating | MD |
01/19 | ASTRAZENECA : Thailand defends royal company's role in vaccine strategy | RE |
01/19 | ASTRAZENECA : Thailand defends royal company's role in vaccine strategy | RE |
01/19 | ASTRAZENECA : Sterling slips against euro, analysts see gains | RE |
01/19 | SANOFI : Goldman Sachs gives a Buy rating | MD |
01/19 | GSK, Novartis Announce Collaboration To Support Scientific Research Into Gene.. | RE |
01/18 | Philippines to buy 20 mln doses of Moderna's COVID-19 vaccine | RE |
01/18 | Australia shares jump 1% on reports Queensland to lift lockdown curbs | RE |
01/18 | Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use | RE |
01/18 | ASTRAZENECA : Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency.. | RE |
01/18 | South Africa to get 9 million J&J vaccine shots - ministry | RE |
01/18 | NOVO NORDISK : Buy rating from JP Morgan | MD |
01/18 | BAYER AG : JP Morgan sticks Neutral | MD |
01/18 | SINOVAC BIOTECH : Brazil vaccinations start as country faces vaccine ingredient .. | RE |
01/18 | South Africa is promised 9 million J&J vaccine shots - Business Day | RE |
01/18 | Samsung Elec's worst fall in 5 mths pulls down KOSPI after group leader's pri.. | RE |
01/18 | PRESS RELEASE : ViGeneron announces research collaboration with Daiichi Sankyo t.. | DJ |
01/18 | PRESS RELEASE : Roche Annual General Meeting 2021: Exercising of shareholder rig.. | DJ |
01/17 | ASTRAZENECA : Brazil Starts Its Covid-19 Vaccine Rollout -- 4th Update | DJ |
01/17 | ASTRAZENECA : Brazil Starts Its Covid-19 Vaccine Rollout -- 3rd Update | DJ |
01/17 | ASTRAZENECA : Brazil Authorizes Use of Two Covid-19 Vaccines -- Update | DJ |
01/17 | Brazil Authorizes Use of Two Covid-19 Vaccines | DJ |
01/17 | ASTRAZENECA : Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shot.. | RE |
01/17 | ASTRAZENECA : Brazil regulator to decide on emergency use of Sinovac, AstraZenec.. | RE |
01/16 | Samsung's Jay Y. Lee on cusp of stepping out of father's shadow | RE |
01/15 | New hedge fund Honest Capital gains 88% with bets on cannabis, others | RE |
01/15 | MODERNA : WHO sees poorer countries getting first COVID vaccines this quarter | RE |
01/15 | Bans on GMO corn, glyphosate in Mexico would shrink food supplies, industry s.. | RE |
01/15 | SANOFI : Deutsche Bank Initiates Coverage on Sanofi With Sell Rating | MT |
01/15 | SINOVAC BIOTECH : Brazil airlifts emergency oxygen into pandemic-struck state, v.. | RE |
01/15 | NOVARTIS : Deutsche Bank Starts Novartis at Buy | MT |
01/15 | ASTRAZENECA : Deutsche Bank Initiates Coverage on AstraZeneca With Buy Rating | MT |
01/15 | GLAXOSMITHKLINE : Deutsche Bank Starts GlaxoSmithKline at Hold | MT |
01/15 | NOVO NORDISK A/S : Deutsche Bank Initiates Coverage on Novo Nordisk A/S With Buy.. | MT |
01/15 | BRISTOL MYERS SQUIBB : UBS Adjusts Price Target on Bristol-Myers Squibb to $66 F.. | MT |
01/15 | PRESS RELEASE : BP p.l.c.: BP announces non-executive director resignation | DJ |
01/15 | ELI LILLY AND : Lilly Invests $30 Million in Venture Fund for Underrepresented F.. | DJ |
01/15 | NOVO NORDISK : Buy rating by Deutsche Bank | MD |
01/15 | SANOFI : Gets a Sell rating from Deutsche Bank | MD |
01/15 | ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating | MD |
01/15 | GLAXOSMITHKLINE : Deutsche Bank gives a Neutral rating | MD |
01/15 | NOVARTIS AG : Gets a Buy rating from Deutsche Bank | MD |